These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

334 related items for PubMed ID: 8637704

  • 1. Fusion of the EWS and CHOP genes in myxoid liposarcoma.
    Panagopoulos I, Höglund M, Mertens F, Mandahl N, Mitelman F, Aman P.
    Oncogene; 1996 Feb 01; 12(3):489-94. PubMed ID: 8637704
    [Abstract] [Full Text] [Related]

  • 2. Characteristic sequence motifs at the breakpoints of the hybrid genes FUS/CHOP, EWS/CHOP and FUS/ERG in myxoid liposarcoma and acute myeloid leukemia.
    Panagopoulos I, Lassen C, Isaksson M, Mitelman F, Mandahl N, Aman P.
    Oncogene; 1997 Sep 01; 15(11):1357-62. PubMed ID: 9315104
    [Abstract] [Full Text] [Related]

  • 3. Two distinct FUS breakpoint clusters in myxoid liposarcoma and acute myeloid leukemia with the translocations t(12;16) and t(16;21).
    Panagopoulos I, Mandahl N, Mitelman F, Aman P.
    Oncogene; 1995 Sep 21; 11(6):1133-7. PubMed ID: 7566973
    [Abstract] [Full Text] [Related]

  • 4. Chimeric TLS/FUS-CHOP gene expression and the heterogeneity of its junction in human myxoid and round cell liposarcoma.
    Kuroda M, Ishida T, Horiuchi H, Kida N, Uozaki H, Takeuchi H, Tsuji K, Imamura T, Mori S, Machinami R.
    Am J Pathol; 1995 Nov 21; 147(5):1221-7. PubMed ID: 7485386
    [Abstract] [Full Text] [Related]

  • 5. Genomic PCR detects tumor cells in peripheral blood from patients with myxoid liposarcoma.
    Panagopoulos I, Aman P, Mertens F, Mandahl N, Rydholm A, Bauer HF, Mitelman F.
    Genes Chromosomes Cancer; 1996 Oct 21; 17(2):102-7. PubMed ID: 8913727
    [Abstract] [Full Text] [Related]

  • 6. Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma.
    Crozat A, Aman P, Mandahl N, Ron D.
    Nature; 1993 Jun 17; 363(6430):640-4. PubMed ID: 8510758
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A novel FUS/CHOP chimera in myxoid liposarcoma.
    Panagopoulos I, Mertens F, Isaksson M, Mandahl N.
    Biochem Biophys Res Commun; 2000 Dec 29; 279(3):838-45. PubMed ID: 11162437
    [Abstract] [Full Text] [Related]

  • 9. Additional evidence of a variant translocation t(12;22) with EWS/CHOP fusion in myxoid liposarcoma: clinicopathological features.
    Dal Cin P, Sciot R, Panagopoulos I, Aman P, Samson I, Mandahl N, Mitelman F, Van den Berghe H, Fletcher CD.
    J Pathol; 1997 Aug 29; 182(4):437-41. PubMed ID: 9306965
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Characteristics of genomic breakpoints in TLS-CHOP translocations in liposarcomas suggest the involvement of Translin and topoisomerase II in the process of translocation.
    Kanoe H, Nakayama T, Hosaka T, Murakami H, Yamamoto H, Nakashima Y, Tsuboyama T, Nakamura T, Ron D, Sasaki MS, Toguchida J.
    Oncogene; 1999 Jan 21; 18(3):721-9. PubMed ID: 9989822
    [Abstract] [Full Text] [Related]

  • 13. Prognostic impact of P53 status, TLS-CHOP fusion transcript structure, and histological grade in myxoid liposarcoma: a molecular and clinicopathologic study of 82 cases.
    Antonescu CR, Tschernyavsky SJ, Decuseara R, Leung DH, Woodruff JM, Brennan MF, Bridge JA, Neff JR, Goldblum JR, Ladanyi M.
    Clin Cancer Res; 2001 Dec 21; 7(12):3977-87. PubMed ID: 11751490
    [Abstract] [Full Text] [Related]

  • 14. TLS/FUS fusion domain of TLS/FUS-erg chimeric protein resulting from the t(16;21) chromosomal translocation in human myeloid leukemia functions as a transcriptional activation domain.
    Prasad DD, Ouchida M, Lee L, Rao VN, Reddy ES.
    Oncogene; 1994 Dec 21; 9(12):3717-29. PubMed ID: 7970732
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Analysis of FUS-CHOP fusion transcripts in different types of soft tissue liposarcoma and their diagnostic implications.
    Willeke F, Ridder R, Mechtersheimer G, Schwarzbach M, Duwe A, Weitz J, Lehnert T, Herfarth C, von Knebel Doeberitz M.
    Clin Cancer Res; 1998 Jul 21; 4(7):1779-84. PubMed ID: 9676855
    [Abstract] [Full Text] [Related]

  • 17. Comparable transforming capacities and differential gene expression patterns of variant FUS/CHOP fusion transcripts derived from soft tissue liposarcomas.
    Schwarzbach MH, Koesters R, Germann A, Mechtersheimer G, Geisbill J, Winkler S, Niedergethmann M, Ridder R, Buechler MW, von Knebel Doeberitz M, Willeke F.
    Oncogene; 2004 Sep 02; 23(40):6798-805. PubMed ID: 15286712
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Fusion of the EWS-related gene TAF2N to TEC in extraskeletal myxoid chondrosarcoma.
    Sjögren H, Meis-Kindblom J, Kindblom LG, Aman P, Stenman G.
    Cancer Res; 1999 Oct 15; 59(20):5064-7. PubMed ID: 10537274
    [Abstract] [Full Text] [Related]

  • 20. Characterization of the CHOP breakpoints and fusion transcripts in myxoid liposarcomas with the 12;16 translocation.
    Panagopoulos I, Mandahl N, Ron D, Höglund M, Nilbert M, Mertens F, Mitelman F, Aman P.
    Cancer Res; 1994 Dec 15; 54(24):6500-3. PubMed ID: 7987849
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.